Skip to main content
. 2013 Sep 18;8(9):e74538. doi: 10.1371/journal.pone.0074538

Figure 4. Examples of candidate compounds on drug screening.

Figure 4

(A) The five selected compounds inhibited SPS formation (magnification, 200×). (B) Niclosamide inhibited MCF7 SPS formation. The SP of MCF7 was treated with 3 µM or 30 µM niclosamide for 48 h (magnification, 50×). Images of MCF7 SPS culture were analyzed using the Image-Pro Plus 6.0 software. (C) Niclosamide decreased the fraction of MCF7 SP. Treatment with niclosamide decreased the SP fraction in MCF7 and MDA-MB-231 cells. (D) MCF7 SPS were treated with niclosamide (3 µM) for 72 h. Apoptosis was evaluated using flow cytometry.